Source: Jim Hoft

A woman from King County, Washington, who was in her late 30’s, has died from a rare blood-clotting syndrome after receiving Johnson & Johnson vaccine on September 7, according to a statement by Public Health – Seattle & King County.

The woman, whose identity was not disclosed, received her vaccination on August 26, 2021. After 11 days of getting the vaccine, she died on September 7 with thrombosis with thrombocytopenia syndrome (TTS).

The CDC verified that the woman indeed died from the vaccine and confirmed the diagnosis.

The Washington State Department of Health released a statement regarding the recent death of the woman:

“Sadly, this is the first such death in Washington State. We send our deepest condolences to her family and loved ones. Losing a loved one at any time is a tragic and difficult and pain that’s become all too familiar in the last year and a half of this pandemic.” says Umair A. Shah, MD, MPH, Secretary of Health.

A 20-year-old woman in Slovenia suffered the same fate and died two weeks after taking the J&J shot.

More from Aljazeera:

Slovenia has suspended vaccinations with the Johnson & Johnson coronavirus jab while it probes the death of a 20-year-old woman, as thousands gathered to protest against vaccination in the small European Union nation.

The suspension will be in place until experts examine whether there is a link between the woman’s death from a stroke and the vaccine she received two weeks earlier, Health Minister Janez Poklukar said on Wednesday.

Despite the risk of the vaccine, one-shot Johnson & Johnson had submitted an application to the F.D.A for emergency use authorization of a booster shot in people aged 18 and older and is planning to submit data to WHO and to other health agencies.

J&J said that the booster shot will increase effectiveness to 94%, given about two months after the first shot. If approve, J&J will be no longer a one-shot vaccine.

The Biden administration previously called on states to ‘pause’ the J&J vaccine after reports of blood clots in women aged 18-48–including one fatality–out of about seven million administered vaccines.